PureTech Health PLC
NASDAQ:PRTC

Watchlist Manager
PureTech Health PLC Logo
PureTech Health PLC
NASDAQ:PRTC
Watchlist
Price: 22.845 USD 0.73% Market Closed
Market Cap: 546.7m USD
Have any thoughts about
PureTech Health PLC?
Write Note

Intrinsic Value

PRTC's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one PRTC stock under the Base Case scenario is 4.917 USD. Compared to the current market price of 22.845 USD, PureTech Health PLC is Overvalued by 78%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PRTC Intrinsic Value
4.917 USD
Overvaluation 78%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
PureTech Health PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for PRTC cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about PRTC?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Biotechnology Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about PureTech Health PLC

Provide an overview of the primary business activities
of PureTech Health PLC.

What unique competitive advantages
does PureTech Health PLC hold over its rivals?

What risks and challenges
does PureTech Health PLC face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for PureTech Health PLC.

Provide P/S
for PureTech Health PLC.

Provide P/E
for PureTech Health PLC.

Provide P/OCF
for PureTech Health PLC.

Provide P/FCFE
for PureTech Health PLC.

Provide P/B
for PureTech Health PLC.

Provide EV/S
for PureTech Health PLC.

Provide EV/GP
for PureTech Health PLC.

Provide EV/EBITDA
for PureTech Health PLC.

Provide EV/EBIT
for PureTech Health PLC.

Provide EV/OCF
for PureTech Health PLC.

Provide EV/FCFF
for PureTech Health PLC.

Provide EV/IC
for PureTech Health PLC.

Show me price targets
for PureTech Health PLC made by professional analysts.

What are the Revenue projections
for PureTech Health PLC?

How accurate were the past Revenue estimates
for PureTech Health PLC?

What are the Net Income projections
for PureTech Health PLC?

How accurate were the past Net Income estimates
for PureTech Health PLC?

What are the EPS projections
for PureTech Health PLC?

How accurate were the past EPS estimates
for PureTech Health PLC?

What are the EBIT projections
for PureTech Health PLC?

How accurate were the past EBIT estimates
for PureTech Health PLC?

Compare the revenue forecasts
for PureTech Health PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of PureTech Health PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of PureTech Health PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of PureTech Health PLC compared to its peers.

Compare the P/E ratios
of PureTech Health PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing PureTech Health PLC with its peers.

Analyze the financial leverage
of PureTech Health PLC compared to its main competitors.

Show all profitability ratios
for PureTech Health PLC.

Provide ROE
for PureTech Health PLC.

Provide ROA
for PureTech Health PLC.

Provide ROIC
for PureTech Health PLC.

Provide ROCE
for PureTech Health PLC.

Provide Gross Margin
for PureTech Health PLC.

Provide Operating Margin
for PureTech Health PLC.

Provide Net Margin
for PureTech Health PLC.

Provide FCF Margin
for PureTech Health PLC.

Show all solvency ratios
for PureTech Health PLC.

Provide D/E Ratio
for PureTech Health PLC.

Provide D/A Ratio
for PureTech Health PLC.

Provide Interest Coverage Ratio
for PureTech Health PLC.

Provide Altman Z-Score Ratio
for PureTech Health PLC.

Provide Quick Ratio
for PureTech Health PLC.

Provide Current Ratio
for PureTech Health PLC.

Provide Cash Ratio
for PureTech Health PLC.

What is the historical Revenue growth
over the last 5 years for PureTech Health PLC?

What is the historical Net Income growth
over the last 5 years for PureTech Health PLC?

What is the current Free Cash Flow
of PureTech Health PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for PureTech Health PLC.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
PureTech Health PLC

Balance Sheet Decomposition
PureTech Health PLC

Current Assets 508.8m
Cash & Short-Term Investments 502.1m
Receivables 2.1m
Other Current Assets 4.7m
Non-Current Assets 71.1m
Long-Term Investments 29m
PP&E 17.3m
Intangibles 906k
Other Non-Current Assets 23.9m
Current Liabilities 138.3m
Accounts Payable 8.1m
Accrued Liabilities 23.3m
Other Current Liabilities 106.9m
Non-Current Liabilities 125.8m
Long-Term Debt 16.4m
Other Non-Current Liabilities 109.3m
Efficiency

Earnings Waterfall
PureTech Health PLC

Revenue
468k USD
Operating Expenses
-136.9m USD
Operating Income
-136.4m USD
Other Expenses
54m USD
Net Income
-82.5m USD

Free Cash Flow Analysis
PureTech Health PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

PRTC Profitability Score
Profitability Due Diligence

PureTech Health PLC's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
ROE is Increasing
Negative 1-Year Revenue Growth
Declining ROIC
17/100
Profitability
Score

PureTech Health PLC's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

PRTC Solvency Score
Solvency Due Diligence

PureTech Health PLC's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Short-Term Solvency
Long-Term Solvency
51/100
Solvency
Score

PureTech Health PLC's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PRTC Price Targets Summary
PureTech Health PLC

Wall Street analysts forecast PRTC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRTC is 74.143 USD with a low forecast of 60.846 USD and a high forecast of 89.392 USD.

Lowest
Price Target
60.846 USD
166% Upside
Average
Price Target
74.143 USD
225% Upside
Highest
Price Target
89.392 USD
291% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for PRTC?

Click here to dive deeper.

Dividends

PureTech Health PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for PRTC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

PureTech Health PLC Logo
PureTech Health PLC

Country

United States of America

Industry

Biotechnology

Market Cap

412.3m GBP

Dividend Yield

0%

Description

PureTech Health Plc engages in the provision of differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders. The company is headquartered in Boston, Massachusetts and currently employs 66 full-time employees. The company went IPO on 2015-06-19. The firm is engaged in discovering, developing and commercializing medicines for diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders. The firm's wholly owned pipeline consists of six therapeutic candidates including LYT-100 (deupirfenidone), LYT-200, LYT-210, LYT-300 (oral allopregnanolone), LYT-500, and LYT-503/IMB-150. Its segments include Internal, Controlled Founded Entity, Non-Controlled Founded Entities, and Parent Company and Other. Its Internal segment is advancing wholly owned programs designed to harness immunological, fibrotic and lymphatic system mechanisms. These classes of immunomodulatory drugs are designed to treat serious diseases, including lung dysfunction, immuno-oncology, lymphatic, neurological and neuropsychological disorders.

Contact

MASSACHUSETTS
Boston
501 Boylston St Ste 6102
+16174822333.0
puretechhealth.com

IPO

2015-06-19

Employees

66

Officers

CEO & Executive Director
Dr. Bharatt M. Chowrira J.D., Ph.D.
Founder, Senior Advisor & Board Observer
Ms. Daphne Zohar
Co-Founder & Non-Executive Director
Dr. Robert S. Langer Jr., Ph.D., ScD
Co-Founder & President
Dr. Eric Elenko Ph.D.
Co-Founder & Senior Advisor
Dr. David R. Elmaleh Ph.D.
Senior Vice President of Finance
Mr. Michael Inbar CPA, M.B.A.
Show More
Chief Operating Officer
Mr. Eric Green M.B.A.
Head of Communications & Investor Relations
Ms. Allison Mead Talbot
General Counsel & Company Secretary
Mr. Charles Sherwood III, J.D., Ph.D.
Senior Vice President of Human Resources
Mr. Spencer Ball
Show Less

See Also

Discover More
What is the Intrinsic Value of one PRTC stock?

The intrinsic value of one PRTC stock under the Base Case scenario is 4.917 USD.

Is PRTC stock undervalued or overvalued?

Compared to the current market price of 22.845 USD, PureTech Health PLC is Overvalued by 78%.

Back to Top